Aponjon exposure and use pattern | n = 786 | Knowledge for newborn health care | Practice of newborn health care | ||||
---|---|---|---|---|---|---|---|
% scored ≥50th percentile | Crude OR^ (95% CI) | Adjusted ORa (95% CI) | % scored ≥50th percentile | Crude OR^ (95% CI) | Adjusted ORa (95% CI) | ||
Exposure to Aponjon | |||||||
No exposure (non-user) | 454 | 45.6 | 1.00 | 1.00 | 48.5 | 1.00 | 1.00 |
3–5 months exposure | 51 | 51.0 | 1.24 (0.70–2.21) | 1.19 (0.67–2.12) | 41.2 | 0.74 (0.41–1.34) | 0.77 (0.42–1.40) |
6–12 months exposure | 281 | 56.9 | 1.58 (1.17–2.13) | 1.46 (1.05–2.03) | 54.1 | 1.25 (0.93–1.69) | 1.22 (0.91–1.64) |
Use pattern of Aponjon | |||||||
No exposure (non-user) | 454 | 45.6 | 1.00 | 1.00 | 48.5 | 1.00 | 1.00 |
Did not receive or listen to ≥3 messages per month (poor pattern) | 222 | 52.7 | 1.33 (0.96–1.83) | 1.28 (0.91–1.80) | 47.3 | 0.95 (0.69–1.32) | 0.96 (0.71–1.31) |
Received and listened to ≥3 messages per month (good pattern) | 110 | 62.7 | 2.01 (1.31–3.08) | 1.76 (1.10–2.80) | 61.8 | 1.72 (1.12–2.64) | 1.63 (1.04–2.55) |
Exposure to Aponjon and use pattern | |||||||
No exposure (non-users) | 454 | 45.6 | 1.00 | 1.00 | 48.5 | 1.00 | 1.00 |
Subscribed for 3–5 months and had a poor pattern of use | 41 | 43.9 | 0.93 (0.49–1.78) | 0.91 (0.47–1.77) | 36.6 | 0.61 (0.32–1.19) | 0.64 (0.35–1.16) |
Subscribed for 3–5 months and had a good pattern of use | 10 | 80.0 | 4.77 (1.00–22.72) | 4.30 (1.12–16.52) | 60.0 | 1.60 (0.44–5.73) | 1.65 (0.39–6.97) |
Subscribed for 6–9 months and had a poor patter of use | 181 | 54.7 | 1.44 (1.02–2.04) | 1.38 (0.96–1.99) | 49.7 | 1.05 (0.75–1.48) | 1.06 (0.75–1.48) |
Subscribed for 6–9 months and had a good patter of use | 100 | 61.0 | 1.87 (1.20–2.90) | 1.63 (1.02–2.61) | 62.0 | 1.74 (1.11–2.70) | 1.63 (1.06–2.51) |